Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-κB pathway

Journal of Infectious Diseases

Volumn 188, Issue 1, 2003, Pages 108-113

  Niessner, Alexander ^a   Kaun, Christoph ^a   Zorn, Gerlinde ^a   Speidl, Walter ^a   Türel, Zeynep ^a   Christiansen, Gunna ^b   Pedersen, Anna Sofie ^b   Birkelund, Svend ^b   Simon, Susan ^a   Georgopoulos, Apostolos ^a   Graninger, Wolfgang ^a   De Martin, Rainer ^a   Lipp, Joachim ^a   Binder, Bernd R ^a   Maurer, Gerald ^a   Huber, Kurt ^a   Wojta, Johann ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b AARHUS UNIVERSITY   (Denmark)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYMORPHIC MEMBRANE PROTEIN 20; POLYMORPHIC MEMBRANE PROTEIN 21; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CELL CULTURE; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG PURIFICATION; DRUG SCREENING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

BACTERIAL OUTER MEMBRANE PROTEINS; CELLS, CULTURED; CHEMOKINE CCL2; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 0037898179     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375827     Document Type: Article

References (37)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-6.
2. Saikku P. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 1999; 138:S500-3.
3. Davidson M, Kuo CC, Middaugh JP, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998; 98:628-33.
4. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity. Circulation 2001; 103:1390-5.
5. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000; 31:1521-5.
6. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92:6911-4.
7. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin Microbiol Infect 2002; 8:2-13.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
9. Dechend R, Maass M, Gieffers J, et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999; 100:1369-73.
10. Molestina RE, Miller RD, Lentsch AB, Ramirez JA, Summersgill JT. Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells. Infect Immun 2000; 68:4282-8.
11. Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999; 103:571-7.
12. Krull M, Klucken AC, Wuppermann FN, et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999; 162:4834-41.
13. Netea MG, Selzman CH, Kullberg BJ, et al. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30:541-9.
14. Pedersen AS, Christiansen G, Birkelund S. Differential expression of Pmp10 in cell culture infected with Chlamydia pneumoniae CWL029. FEMS Microbiol Lett 2001; 203:153-9.
15. Christiansen G, Pedersen AS, Hjerno K, Vandahl B, Birkelund S. Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine. J Infect Dis 2000; 181(Suppl 3):S528-37.
16. Shirai M, Hirakawa H, Ouchi K, et al. Comparison of outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia pneumoniae isolates from Japan and the United States. J Infect Dis 2000; 181(Suppl 3):S524-7.
17. Wojta J, Zoellner H, Gallicchio M, Hamilton JA, McGrath K. Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem Biophys Res Commun 1992; 188:463-9.
18. Chirgwin K, Roblin PM, Hammerschlag MR. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob Agents Chemother 1989; 33:1634-5.
19. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med 1996; 183:1013-22.
20. de Martin R, Raidl M, Hofer E, Binder BR. Adenovirus-mediated expression of green fluorescent protein. Gene Ther 1997; 4:493-5.
21. Bianchi A, Dosquet C, Henry S, Couderc MC, Ferchal F, Scieux C. Chlamydia trachomatis growth stimulates interleukin 8 production by human monocytic U-937 cells. Infect Immun 1997; 65:2434-4.
22. Fryer RH, Schwobe EP, Woods ML and Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med 1997; 45:168-74.
23. Godzik KL, O'Brien ER, Wang SK, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995; 33:2411-4.
24. Summersgill JT, Molestina RE, Miller RD, Ramirez JA. Interactions of Chlamydia pneumoniae with human endothelial cells. J Infect Dis 2000; 181(Suppl 3):S479-82.
25. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168:1435-40.
26. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995; 63:3125-30.
27. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998; 66:5067-72.
28. Christiansen G, Boesen T, Hjerno K, et al. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity. Am Heart J 1999; 138:S491-5.
29. Grimwood J, Olinger L, Stephens RS. Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect Immun 2001; 69:2383-9.
30. Wizel B, Starcher BC, Samten B, et al. Multiple Chlamydia pneumoniae antigens prime CD8(+) Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J Immunol 2002; 169:2524-35.
31. Kukielka GL, Youker KA, Hawkins HK, et al. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann NY Acad Sci 1994; 723:258-70.
32. Seino Y, Ikeda U, Ikeda M, et al. Interteukin 6 gene transcripts are expressed in human atheroscterotic lesions. Cytokine 1994; 6:87-91.
33. Yazdani S, Simon AD, Vidhun R, Gulotta C, Schwartz A, Rabbani LE. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am Heart J 1998; 136:357-61.
34. Seino Y, Ikeda U, Takahashi M, et al. Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine 1995; 7:575-9.
35. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor - deficient mice. Mol Cell 1998; 2:275-81.
36. Gosling J, Slaymaker S, Gu L, et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999; 103:773-8.
37. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109(Suppl):S81-96.